Experts name 3 top ASX shares to buy this week

If you are looking for new additions to your portfolio, then it could be worth listening to what analysts are saying about the top ASX shares named below, courtesy of The Bull. 

Here's what they are recommending this week:

Ramelius Resources Ltd (ASX: RMS)

The team at Fairmont Equities thinks this gold miner could be an ASX share to buy this week.

It likes Ramelius Resources due to its belief that gold stocks will rally higher due to strong gold prices. It said:

Gold prices appear to have bottomed after trading much higher in early 2026. The share prices of various gold mining stocks have held up well, and this sign of strength is bullish. I'm expecting gold mining stock prices to rally higher from here as they follow potentially higher gold prices. 

RMS is an Australian gold producer with no debt and strong free cash flow. It pays a fully franked dividend and has been buying back shares. RMS is highly leveraged to an increasing gold price and the company's outlook is bright.

Sigma Healthcare Ltd (ASX: SIG)

Over at Baker Young, it has named Chemist Warehouse owner Sigma Healthcare as an ASX share to buy.

Baker Young sees an opportunity for investors after recent share price weakness. It explains:

Sigma Healthcare is a wholesale distributer of pharmaceutical goods and medicines. Sigma merged with pharmaceutical retail giant Chemist Warehouse in 2025. The company's share price has retreated to appealing entry levels at October 15. Its competitive position remains unrivalled, in our view. Structural health trends should continue to support organic growth. 

Although some competition is likely, the GLP-1 weight loss drug rollout should boost treatment sales. The Chemist Warehouse branded store network is forecast to generate double digit, like-for-like sales growth in full year 2027.

Xero Ltd (ASX: XRO)

Baker Young is also feeling positive about cloud accounting platform provider Xero and thinks it could be an ASX share to buy now.

It sees the material decline in the Xero share price as a buying opportunity for investors. Especially given its view that small to medium sized businesses will continue to use accounting and payment software rather than using AI to develop their own systems. It explains:

Xero is an accounting software provider. Concerns about future growth rates due to perceived competitive threats from AI tools remain. But we believe the material decline in XRO's share price amid the company continuing to deliver operational performance inline or above market guidance has created a compelling value opportunity. 

We believe small to medium sized firms handling critical financial information will continue using trusted third party suppliers rather than develop their own systems. XRO's strong growth rates justify higher than average multiples, in our view. We're comfortable building positions for longer term investors around current levels.

The post Experts name 3 top ASX shares to buy this week appeared first on The Motley Fool Australia.

Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026